Literature DB >> 16337807

Metabolic emergencies.

Silvia Spinazzé1, Dirk Schrijvers.   

Abstract

Life-threatening metabolic complications observed in cancer patients are: hypercalcaemia, hyponatremia, hyperurcaemia, tumour lysis syndrome, hypoglycaemia, hyperuremia and hypercreatininemia secondary to renal failure, hyperammoniemia, lactic acidosis and adrenal failure. They may be associated with any kind of neoplastic disease causing dysfunction of vital organs, which can be determined by neoplastic spread, anti-cancer treatment or, more rarely, by paraneoplastic phenomena. The clinical presentation of metabolic complications is typically aspecific. Encephalopathy, raging from mild confusion to coma, is the most common and clinically most severe symptom. The severity of consciousness impairment is related to both the rate of onset and the magnitude of the metabolic disorder. The definitive diagnosis will be established by laboratory examination and radiological work-up. Cancer patients presenting metabolic should be referred to oncologic departments or intensive care units. The treatment of metabolic disorders include: prophylactic measures, emergency measures to preserve vital functions and to restore biological parameters and the treatment of the underlying primary.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337807     DOI: 10.1016/j.critrevonc.2005.04.004

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  8 in total

1.  Type B lactic acidosis: a rare but life threatening hematologic emergency. A case illustration and brief review.

Authors:  Wederson M Claudino; Ajoy Dias; William Tse; Vivek R Sharma
Journal:  Am J Blood Res       Date:  2015-06-15

Review 2.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

Review 3.  Paraneoplastic syndromes: an approach to diagnosis and treatment.

Authors:  Lorraine C Pelosof; David E Gerber
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

4.  Intravascular B-cell lymphoma with hypercalcemia as the initial presentation.

Authors:  Yoshiaki Chinen; Mitsushige Nakao; Mio Sugitani-Yamamoto; Miki Kiyota; Shigeo Horiike; Junya Kuroda; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2011-11-03       Impact factor: 2.490

5.  Neuroendocrine carcinoma of the cervix presenting as intractable hyponatremic seizures due to paraneoplastic SIADH-a rare case report and brief review of the literature.

Authors:  Santhosh Kuriakose; N Umadevi; Sheela Mathew; Nk Supriya; Kp Aravindan; Ds Smitha; G Amritha Malini
Journal:  Ecancermedicalscience       Date:  2014-07-31

Review 6.  Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.

Authors:  Sondra O'Callaghan; Hanford Yau
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

7.  Case Report: Hematologic Recovery Following Stereotactic Ablative Radiotherapy in a Patient With Early-Stage Non-Small Cell Lung Cancer and Paraneoplastic Myelofibrosis.

Authors:  Lindsey Sloan; Rakhi P Naik; Kavita Umrau; Rena Ruiyu Xian; Kristen A Marrone; Khinh Ranh Voong
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

8.  Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms.

Authors:  Kosmas Daskalakis; Eleftherios Chatzelis; Marina Tsoli; Nektaria Papadopoulou-Marketou; Georgios K Dimitriadis; Apostolos V Tsolakis; Gregory Kaltsas
Journal:  Endocrine       Date:  2018-10-02       Impact factor: 3.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.